These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 10374782)
1. Survival in small cell lung carcinoma is independent of Bcl-2 expression. Maitra A; Amirkhan RH; Saboorian MH; Frawley WH; Ashfaq R Hum Pathol; 1999 Jun; 30(6):712-7. PubMed ID: 10374782 [TBL] [Abstract][Full Text] [Related]
2. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer. Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534 [TBL] [Abstract][Full Text] [Related]
3. Bcl-2 as a prognostic factor for survival in small-cell lung cancer. Ilievska Poposka B; Smickova S; Jovanovska Crvenkovska S; Zafirovska Ivanovska B; Stefanovski T; Petrusevska G Prilozi; 2008 Dec; 29(2):281-93. PubMed ID: 19259053 [TBL] [Abstract][Full Text] [Related]
4. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. LaPoint RJ; Bourne PA; Wang HL; Xu H Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382 [TBL] [Abstract][Full Text] [Related]
5. Small cell carcinomas of the lung express the Bcl-2 protein. Ben-Ezra JM; Kornstein MJ; Grimes MM; Krystal G Am J Pathol; 1994 Nov; 145(5):1036-40. PubMed ID: 7977636 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas. Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391 [TBL] [Abstract][Full Text] [Related]
7. c-erbB-2 expression in small-cell lung cancer is associated with poor prognosis. Micke P; Hengstler JG; Ros R; Bittinger F; Metz T; Gebhard S; Beeh KM; Oesch F; Buhl R Int J Cancer; 2001 May; 92(4):474-9. PubMed ID: 11304679 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer. Paik KH; Park YH; Ryoo BY; Yang SH; Lee JC; Kim CH; Ki SS; Kim JM; Park MJ; Ahn HJ; Choi W; Chung JH J Korean Med Sci; 2006 Feb; 21(1):35-9. PubMed ID: 16479062 [TBL] [Abstract][Full Text] [Related]
9. Kit expression in small cell carcinomas of the lung: effects of chemotherapy. Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988 [TBL] [Abstract][Full Text] [Related]
10. High expression of integrin beta1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. Oshita F; Kameda Y; Hamanaka N; Saito H; Yamada K; Noda K; Mitsuda A Am J Clin Oncol; 2004 Jun; 27(3):215-9. PubMed ID: 15170136 [TBL] [Abstract][Full Text] [Related]
11. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications. Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468 [TBL] [Abstract][Full Text] [Related]
12. The role of c-erbB-2 expression on the survival of patients with small-cell lung cancer. Canoz O; Ozkan M; Arsav V; Er O; Coskun HS; Soyuer S; Altinbas M Lung; 2006; 184(5):267-72. PubMed ID: 17235726 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer. Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980 [TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival. Laudanski J; Chyczewski L; Niklińska WE; Kretowska M; Furman M; Sawicki B; Nikliński J Neoplasma; 1999; 46(1):25-30. PubMed ID: 10355530 [TBL] [Abstract][Full Text] [Related]
15. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737. Tahir SK; Yang X; Anderson MG; Morgan-Lappe SE; Sarthy AV; Chen J; Warner RB; Ng SC; Fesik SW; Elmore SW; Rosenberg SH; Tse C Cancer Res; 2007 Feb; 67(3):1176-83. PubMed ID: 17283153 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small-cell lung cancer. Hwang JH; Lim SC; Kim YC; Park KO; Ahn SJ; Chung WK Int J Radiat Oncol Biol Phys; 2001 May; 50(1):13-8. PubMed ID: 11316541 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas. Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783 [TBL] [Abstract][Full Text] [Related]
19. Bcl-2 expression correlates with apoptosis induction but not loss of clonogenic survival in small cell lung cancer cell lines treated with etoposide. Breton C; Story MD; Meyn RE Anticancer Drugs; 1998 Oct; 9(9):751-7. PubMed ID: 9840719 [TBL] [Abstract][Full Text] [Related]
20. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. Jiang SX; Sato Y; Kuwao S; Kameya T J Pathol; 1995 Oct; 177(2):135-8. PubMed ID: 7490679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]